LENVATINIB vs LETERMOVIR: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
LENVATINIB vs LETERMOVIR: Safety Overview
| Metric | LENVATINIB | LETERMOVIR |
|---|---|---|
| Total FAERS Reports | 33,766 | 1,416 |
| Deaths Reported | 4,449 | 252 |
| Death Rate | 13.2% | 17.8% |
| Hospitalizations | 19,975 | 398 |
| Average Patient Age | 65.4 yrs | 46.6 yrs |
| % Female Patients | 55.8% | 42.7% |
| FDA Approval Date | Feb 13, 2015 | Aug 30, 2024 |
| Manufacturer | Eisai Inc. | Merck Sharp & Dohme LLC |
| Route | ORAL | ORAL |
| Marketing Status | Prescription | Prescription |